Chembio Diagnostics, Inc. (CEMI): Price and Financial Metrics

Chembio Diagnostics, Inc. (CEMI)

Today's Latest Price: $6.45 USD

0.14 (2.22%)

Updated Jan 25 3:25pm

Add CEMI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 64 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

CEMI Stock Summary

  • In terms of twelve month growth in earnings before interest and taxes, Chembio Diagnostics Inc is reporting a growth rate of 50.56%; that's higher than 81.55% of US stocks.
  • The volatility of Chembio Diagnostics Inc's share price is greater than that of 91.67% US stocks with at least 200 days of trading history.
  • Chembio Diagnostics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -22.15%, greater than the shareholder yield of just 11.76% of stocks in our set.
  • Stocks that are quantitatively similar to CEMI, based on their financial statements, market capitalization, and price volatility, are VJET, SANW, AMOT, MDRX, and HTGM.
  • Visit CEMI's SEC page to see the company's official filings. To visit the company's web site, go to

CEMI Stock Price Chart Interactive Chart >

Price chart for CEMI

CEMI Price/Volume Stats

Current price $6.45 52-week high $15.89
Prev. close $6.31 52-week low $2.25
Day low $6.01 Volume 760,302
Day high $6.53 Avg. volume 1,109,873
50-day MA $5.51 Dividend yield N/A
200-day MA $6.37 Market Cap 130.14M

Chembio Diagnostics, Inc. (CEMI) Company Bio

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. The company was founded in 1985 and is based in Medford, New York.

CEMI Latest News Stream

Event/Time News Detail
Loading, please wait...

CEMI Latest Social Stream

Loading social stream, please wait...

View Full CEMI Social Stream

Latest CEMI News From Around the Web

Below are the latest news stories about Chembio Diagnostics Inc that investors may wish to consider to help them evaluate CEMI as an investment opportunity.

Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems

Enters Exclusive U.K. and Ireland Distribution Agreement with Luas DiagnosticsHAUPPAUGE, N.Y., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the CE mark for the DPP SARS-CoV-2 Antigen and IgM/IgG test systems, providing regulatory approval to register and market both test systems in the European Union and other geographies that accept the CE mark. The Company also announced that it has entered into a distribution agreement with Luas Diagnostics, which will commence system sales immediately while serving as the exclusive commercial partner for all of Chembio’s products in the United Kingdom and Ireland. “Having the CE mark for both COVID-19 test systems is indicative ...

Yahoo | January 14, 2021

Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors

HAUPPAUGE, N.Y., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Company’s Board of Directors. “We are pleased to welcome David to our Board of Directors. He adds directly applicable expertise in public health and infectious disease management to our leadership team, and we are confident his perspective will contribute meaningfully to our long-term value creation strategy,” said Katherine L. Davis, Chair of Chembio's Board of Directors. “We look forward to his leadership and insights as we enter the next phase of growth for Chembio.”Dr. David Acheson has served as the President and Chief Executive Officer of The Acheson Gro...

Yahoo | December 17, 2020

Is Chembio Diagnostics (NASDAQ:CEMI) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Yahoo | December 5, 2020

Are Options Traders Betting on a Big Move in Chembio Diagnostics (CEMI) Stock?

Investors need to pay close attention to Chembio Diagnostics (CEMI) stock based on the movements in the options market lately.

Yahoo | December 4, 2020

Chembio Diagnostics (CEMI) Surges: Stock Moves 8.5% Higher

Chembio Diagnostics (CEMI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Yahoo | December 3, 2020

Read More 'CEMI' Stories Here

CEMI Price Returns

1-mo N/A
3-mo 28.49%
6-mo 27.47%
1-year 53.57%
3-year -23.21%
5-year 47.26%
YTD 35.79%
2020 4.17%
2019 -19.43%
2018 -30.98%
2017 20.59%
2016 27.58%

Continue Researching CEMI

Want to see what other sources are saying about Chembio Diagnostics Inc's financials and stock price? Try the links below:

Chembio Diagnostics Inc (CEMI) Stock Price | Nasdaq
Chembio Diagnostics Inc (CEMI) Stock Quote, History and News - Yahoo Finance
Chembio Diagnostics Inc (CEMI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8775 seconds.